scispace - formally typeset
F

Fabio Benfenati

Researcher at Istituto Italiano di Tecnologia

Publications -  424
Citations -  24243

Fabio Benfenati is an academic researcher from Istituto Italiano di Tecnologia. The author has contributed to research in topics: Synapsin & Synapsin I. The author has an hindex of 77, co-authored 406 publications receiving 21422 citations. Previous affiliations of Fabio Benfenati include University of Padua & University of Modena and Reggio Emilia.

Papers
More filters
Journal ArticleDOI

Anti-synapsin monoclonal antibodies: epitope mapping and inhibitory effects on phosphorylation and Grb2 binding.

TL;DR: The epitopes of a panel of monoclonal antibodies raised against synapsin I and II are localized and their ability to interfere with the interactions of the synapsins with protein kinases, actin and Src homology-3 (SH3) domains is characterized.
Journal ArticleDOI

Nonsense-mediated mRNA decay and loss-of-function of the protein underlie the X-linked epilepsy associated with the W356× mutation in synapsin I.

TL;DR: Data indicate that in patients carrying the W356× mutation the function of synapsin I is markedly impaired, due to both the strongly decreased translation and the altered function of the NMD-escaped protein, and support the value of Syn1−/− mice as an experimental model mimicking the human pathology.
Journal ArticleDOI

Octopus arm regeneration: Role of acetylcholinesterase during morphological modification ☆

TL;DR: It is suggested that AChE protein may have an important influence in the process of regeneration and that it could be considered as a potential target to promote or regulate the regenerative process.
Journal ArticleDOI

2-Deoxy-d-glucose enhances tonic inhibition through the neurosteroid-mediated activation of extrasynaptic GABAA receptors.

TL;DR: The ability of 2‐deoxy‐d‐glucose (2‐DG), a glucose analog that inhibits glycolytic enzymes, of potentiating γ‐aminobutyric acid (GABA)ergic tonic inhibition via neurosteroid‐mediated activation of extrasynaptic GABAA receptors is reported.